Thursday 20th June 2019 |
||
|
8.30 |
Registration | Front Desk |
|
9.15 |
Welcome | Àngel Font, La Caixa Banking Foundation.
(TBD), Departament de Salut – Generalitat de Catalunya, Spain. Roger Paredes, IrsiCaixa. Hospital Germans Trias i Pujol. Fight AIDS Foundation. Badalona, Spain. Francisco Guarner, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain. |
| Session 1: Immune Modulation | CHAIR: Bonaventura Clotet, IrsiCaixa. Hospital Germans Trias i Pujol. Fight AIDS Foundation. Badalona, Spain | |
|
9.30 – 10.30 |
Vaccines and the microbiome | Dario Gutierrez, Merck Exploratory Science Center. Cambridge, MA, USA. |
| Multiple Sclerosis | Hartmut Wekerle, Max Planck Institute of Neurobiology. Munich, Germany. | |
|
10.30-11.00 |
Overall discussion | |
| 11.00-11.30 |
Coffee Break |
|
| Session 2: Cancer | CHAIR: Josep Tabernero, Vall d’Hebron Institute of Oncology (VHIO). Barcelona, Spain. | |
|
11.30 – 12.30 |
Microbiome in colon cancer | Alberto Martin, University of Toronto, Canada. |
| Microbiome and immune checkpoint inhibitors | Laurence Zitvogel, Institut Gustave Roussy. Paris, France. | |
|
12.30-13.00 |
Overall discussion | |
| 13.00-14.00 |
Lunch and poster viewing |
|
| Session 3: Cancer | CHAIR: Paolo G. Nuciforo, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. | |
|
14.00 – 15.00 |
Implications of the gut and oral microbiome dysbiosis in pancreatic cancer aetiology | Esther Molina-Montes, Spanish National Cancer Research Centre (CNIO). Madrid, Spain. |
| Intratumor bacteria and cancer therapeutics | Ravid Straussman, Weizmann Institute of Science. Rehovot, Israel. | |
|
15.00-15.30 |
Overall discussion | |
| 15.30-16.00 |
Coffee Break |
|
| Session 4: Digestive Diseases | CHAIRS: J. M. Fernandez Real, Dr. Josep Trueta Girona University Hospital. Spain
Natalia Borruel, Vall d’Hebron University Hospital. Barcelona, Spain. |
|
|
16.00 – 17.00 |
Inflammatory bowel disease (IBD) | Harry Sokol, Saint-Antoine Hospital. Paris, France |
| Metabolic disorders and fatty liver | Tony Wu, Institute of Medicine, University of Gothenburg, Sweden. | |
|
17.00-17.30 |
Overall discussion | |
| 17.30 |
Adjourn |
|
Friday 21st June 2019 |
||
| Session 5: Compositional Analysis | CHAIRS: M. Luz Calle, University of Vic. Spain
Marc Noguera i Julian, IrsiCaixa. Badalona, Spain. |
|
|
9.30 – 10.30 |
Why microbiome data are compositional? | Vera Pawlowsky-Glahn, University of Girona, Spain. |
| Causes and implication of compositionality on microbiome interpretation | Gregory Gloor, University of Western Ontario, Canada. | |
|
10.30-11.00 |
Overall discussion | |
| 11.00-11.30 |
Coffee Break |
|
| Session 6: Infectious Diseases | CHAIR: Roger Paredes, IrsiCaixa. Hospital Germans Trias i Pujol. Fight AIDS Foundation. badalona, Spain. | |
|
11.30 – 12.30 |
Effects of FMT on antimicrobial resistance clearance | Grzegorz Basak, Medical University of Warsaw, Poland. |
| Microbiome transmission in the immunocompromised host | Ami S. Bhatt, Stanford Medical School. California, USA. | |
|
12.30-13.00 |
Overall discussion | |
| 13.00-14.00 |
Lunch and poster viewing |
|
| Session 7: Functional Analysis | CHAIRS: Chaysavanh Manichanh, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain.
M. Carmen Collado, Institute of Agrochemistry and Food Technology (IATA-CSIC). Valencia, Spain. |
|
|
14.00 – 15.00 |
The gut metabolome in HIV infection | Marc Noguera i Julian, IrsiCaixa. Badalona, Spain. |
| Systems Ecology of the Human Microbiome | Paul Wilmes, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg. | |
|
15.00-15.30 |
Overall discussion |
|
|
15.30-16.00 |
Translating microbiome science – Insights into The future | Joël Doré, French National Institute for Agricultural Research (INRA). France. |
|
16.00-16.30 |
Meeting Closure | Francisco Guarner, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain. |